Real ChatGPT answer · index seed9tePdAtwpk0completeHealth and wellness · common conditions and symptomsbrand
What are the hidden costs of managing type two diabetes symptoms with lifestyle changes versus modern GLP-1 medications for self employed individuals?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What are the hidden costs of managing type two diabetes symptoms with lifestyle changes versus modern GLP-1 medications for self employed individuals?
4 real searches · 1 real-search pass
type 2 diabetes lifestyle intervention costs time burden self management economic costs self employed work productivityGoogle ↗
OBSERVED
GLP-1 receptor agonists type 2 diabetes cost out of pocket insurance coverage discontinuation weight regain adverse effects 2025 2026Google ↗
OBSERVED
ADA Standards of Care 2026 type 2 diabetes lifestyle GLP-1 cardiovascular kidney benefits adverse effectsGoogle ↗
OBSERVED
IRS self employed health insurance deduction prescription medications medical expenses tax treatment 2026Google ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 4 queries…
Searches and sources
ChatGPT4 real searches · gpt-6
type 2 diabetes lifestyle intervention costs time burden self management economic costs self employed work productivity Google ↗
GLP-1 receptor agonists type 2 diabetes cost out of pocket insurance coverage discontinuation weight regain adverse effects 2025 2026 Google ↗
ADA Standards of Care 2026 type 2 diabetes lifestyle GLP-1 cardiovascular kidney benefits adverse effects Google ↗
IRS self employed health insurance deduction prescription medications medical expenses tax treatment 2026 Google ↗
- About Diabetes Self-Management Education and Support | Diabetes · cdc.gov
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2026 | Diabetes Care · diabetesjournals.org
- DailyMed - These highlights do not include all the information needed to use WEGOVY® safely and effectively. See full prescribing information for WEGOVY. WEGOVY (semaglutide) injection, for subcutaneous use WEGOVY (semaglutide) tablets, for oral use Initial U.S. Approval: 2017 · dailymed.nlm.nih.gov
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2026 | Diabetes Care · diabetesjournals.org
- 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 | Diabetes Care · doi.org
- Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. · pubmed.ncbi.nlm.nih.gov
- Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension · pmc.ncbi.nlm.nih.gov
Queries
4 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
type 2 diabetes lifestyle intervention costs time burden self management economic costs self employed work productivity OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
GLP-1 receptor agonists type 2 diabetes cost out of pocket insurance coverage discontinuation weight regain adverse effects 2025 2026 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
ADA Standards of Care 2026 type 2 diabetes lifestyle GLP-1 cardiovascular kidney benefits adverse effects OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
IRS self employed health insurance deduction prescription medications medical expenses tax treatment 2026 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |